The combined treatment of Molnupiravir and Favipiravir results in a marked potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
Authors
Rana Abdelnabi,
Caroline FooSuzanne Kaptein,
Xin Zhang,
Lana Langendries,
Laura Vangeel,
Judith Breuer,
Juanita Pang,
Rachel Williams,
Valentijn Vergote,
Elisabeth Heylen,
Pieter Leyssen,
Kai Dallmeier,
Lotte Coelmont,
Dirk Jochmans,
Arnab Chatterjee,
Steven Jonghe,
Birgit Weynand +16 authors
,
Johan Neyts Tip Tip